This page explains which EpiPen strength to carry and use based on weight (and age as a guide), how quickly epinephrine works, when a second dose is indicated, and special notes for scenarios like children crossing weight bands, higher-weight adults, pregnancy, and cardiac comorbidities. Technique (the how) and side-effect management live on their own pages so this article remains purely about dosage decisions.

Table of Contents

Key takeaways (extractive summary you can surface in an intro box)

Weight decides the strength: ~15–30 kg → 0.15 mg (EpiPen Jr); ≥ ~30 kg → 0.3 mg (EpiPen).
Carry two devices if prescribed; some plans call for a second dose if symptoms persist/worsen after the labeled interval.
Onset is fast (minutes) after intramuscular thigh injection; benefit can wane → observation is essential.
Special cases (near a band, <15 kg, higher-weight adults, pregnancy, cardiac disease) require clinician guidance-not dose avoidance.

Weight-based selection (the clean rule)

Always follow your prescriber’s action plan and the device label for your region. Age below is a guide; weight is the primary criterion.

Weight / Age (guide)	Typical device	Fixed epinephrine dose	How many to carry	Notes
≥ ~30 kg (≈ ≥66 lb)	EpiPen (standard)	0.3 mg (IM)	2	Default adolescent/adult strength in many plans
~15–30 kg (≈ 33–66 lb)	EpiPen Jr	0.15 mg (IM)	2	Pediatric/low-weight users
< ~15 kg	Specialist-directed option	Clinician decision	2	Availability/choice varies by region—requires allergy specialist input
Higher-weight adults	Often still 0.3 mg	0.3 mg (IM)	2	Some regions have alternative fixed-dose devices; specialist will advise

Practical guidance

If a child is approaching 30 kg, clinicians often reassess and consider stepping from 0.15 → 0.3 mg.
If you hover around a threshold, don’t self-switch-confirm with your prescriber which strength to carry.
Many action plans recommend carrying two devices at all times in case a second dose is needed or a device malfunctions.

Onset, peak, and duration (what to expect after the dose)

Onset: Usually within minutes after intramuscular injection into the outer mid-thigh.
What improves first: Breathing effort, voice/stridor, wheeze, and perfusion (dizziness/faintness).
Duration: Initial benefit can wane; symptoms can recur (biphasic) hours later. That’s why post-use observation in a clinical setting is standard after epinephrine.

Second-dose logic (simple, repeatable rule)

Symptoms persist (e.g., breathing difficulty, swelling, dizziness).
Symptoms worsen after partial improvement.
New systemic symptoms appear.

Give the second auto-injector if any of the above are true after the labeled interval from the first dose. Keep the interval visible in your printed action plan. Many plans use 5-15 minutes, but follow your device label and your clinician’s instructions.

Real-world dosing scenarios (and how to handle them)

1) Child crossing a weight band

Reassess when a child is near 30 kg. The prescriber may upgrade to 0.3 mg to ensure adequate dosing.
Update the school action plan, replace devices, and retrain carers/teachers.

2) Families with kids of different sizes

Confirm that each child’s pen strength matches their current weight.
Color-code or label cases (name/strength) to prevent mix-ups during emergencies.

3) Higher-weight adults

Many action plans still specify 0.3 mg auto-injectors. Some regions offer different fixed doses; your allergy specialist will advise based on your profile.
The critical point is speed-do not delay the first dose while debating the ideal milligrams.

4) Remote settings or multiple high-risk allergens

Always carry two devices.
Make sure companions understand the second-dose rule and can execute the injection confidently.

Special populations (concise pointers; full safety lives elsewhere)

These considerations do not mean you withhold epinephrine; they shape monitoring and follow-up.

Pregnancy: Epinephrine remains first-line for anaphylaxis; untreated anaphylaxis is more dangerous to both parent and fetus. Obstetric monitoring follows.
Cardiac disease/arrhythmias or on MAOIs/TCAs/stimulants: Epinephrine can still be life-saving; clinicians will tailor monitoring and adjuncts.
Accidental digital (finger) injection: This is a safety event, not a dose decision-seek urgent care and use your spare for the anaphylaxis patient if needed.

For red-flag symptoms and adverse-effect handling, see EpiPen Side Effects (/epipen-side-effects/).

Dosage FAQs

Is age or weight more important?

Weight. Age is a rough guide; always align the device strength with current body weight.

Can I “split the difference” between 0.15 mg and 0.3 mg?

No. Auto-injectors deliver fixed doses. If you’re near a threshold, ask your prescriber.

How long should I wait before a second dose?

Follow the device label and your action plan. Many plans specify a 5-15 min interval if symptoms persist/worsen.

Does asthma change the dose?

Not the milligrams-but asthma increases respiratory risk. Optimise asthma control and escalate care promptly during anaphylaxis.

Do heavier adults ever need more than 0.3 mg?

Some regions offer alternative fixed-dose devices; a specialist will advise. Never delay the first dose while debating this.

Do I need two devices at both home and school?

Carry two with you; institutions may store spares depending on policy. Align with your action plan.